Volume 8 Issue 4 Archives - Journal for Clinical Studies

Current Edition

Volume 8 Issue 4

Facilitating Cardiology Decision-making at the Point-of-care

As the prevalence of cardiovascular disease (CVD) continues to grow, Rhys Tassell, Point of Care Testing Team Lead at Cambridge University Hospitals NHS Foundation Tr...

16 August 2016 Volume 8 Issue 4

Continue Reading →

Volume 8 Issue 4

Going the Extra Mile: The Role of Temperature-controlled Packaging in a Patient-centric Supply Chain

Getting the right medicine into the hands of a patient in a timely manner has always been the ultimate goal in the clinical supply chain, as Neil Sherman, Technical S...

16 August 2016 Volume 8 Issue 4

Continue Reading →

Volume 8 Issue 4

Embracing the Value of Patient-reported Outcomes: From Clinical Development to Post-marketing Stages

In this article, Sarah Ray, Senior Research Analyst, explores the following issue: amidst a regulatory environment which increasingly focuses on evidence-based resear...

16 August 2016 Volume 8 Issue 4

Continue Reading →

Volume 8 Issue 4

Clinical Trial Pre-screening Methods: A Meta-analysis

A Two-step Pre-screening Process Before Site Referral Improves Efficiency and Reduces Costs Clinical trial recruitment involves three distinct phases: (1) Connecting...

16 August 2016 Volume 8 Issue 4

Continue Reading →

Volume 8 Issue 4

Assessing Cognitive Safety and Tolerability in Drug Trials

According to this article from Charlotte Housden, Head of the Biotechnology and Research Business Unit at Cambridge Cognition, there is increasing pressure on pharmac...

16 August 2016 Volume 8 Issue 4

Continue Reading →

Volume 8 Issue 4

Virexxa – New Opportunity for Patients with Late-stage Endometrial Cancer

Riin Ehin, Chairwoman of the Board and CEO of Competence Centre for Cancer Research, partner and CEO of Bravo Healthcare Ltd., submits a paper on endometrial cancer. ...

16 August 2016 Volume 8 Issue 4

Continue Reading →

Volume 8 Issue 4

Industry and Academia Partnering to Advance Prevention and Treatment of Alzheimer’s Disease

As Markku Toivonen, MD, PhD, chairman of CHMP Scientific Advice Working Party, explains in this piece, according to current evidence, Alzheimer’s disease (AD) is a di...

16 August 2016 Volume 8 Issue 4

Continue Reading →

Volume 8 Issue 4

Market & Regulatory Analysis of Singapore: An Epidemiological Study and Healthcare Research

Mona Dawood, Head of the Pharmaceutical Operations & Regulatory Affairs for CIDP Group, provides an insightful report on Singapore, a fascinating country full of ...

16 August 2016 Volume 8 Issue 4

Continue Reading →

Volume 8 Issue 4

Full Spectrum Clinical Services – From Strategic Souring to Responsive Supply Chain

With the growth of comparative effectiveness research (CER) and the need for large volumes of active comparator medicines comes an increased demand for effective sour...

16 August 2016 Volume 8 Issue 4

Continue Reading →

Volume 8 Issue 4

Regulatory Compliance and Efficiency Savings Key Drivers to eTMF Adoption

Each year, Veeva surveys the pharmaceutical industry on its use of trial master file (TMF) processes. Within this article, Rik van Mol, Vice President of R&D Stra...

16 August 2016 Volume 8 Issue 4

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.